Stock Update (NASDAQ:ILMN): Illumina Expands World’s Most Comprehensive Next-Generation Sequencing Portfolio


(BUSINESS WIRE)–Jan. 12, 2015– Illumina, Inc. (NASDAQ:ILMN) today announced it has expanded the world’s most comprehensive next-generation sequencing (NGS) portfolio with the launch of the HiSeq X Five System and HiSeq 3000/4000 Systems. Over the last five years, the HiSeq Sequencing System family has been established as the platform of choice for high-throughput, production-scale sequencing laboratories. The new… Read more

Shares of Illumina opened today at $195.92 and are currently trading down at $194.32. ILMN has a 1-year high of $199.47 and a 1-year low of $113.15. The stock’s 50-day moving average is $187.99 and it’s 200-day moving average is $177.13.

On the ratings front, Illumina has been the subject of a number of recent research reports. In a report published on January 6, analyst Tycho Peterson from J.P. Morgan assigned a Buy rating to ILMN, with a price target of $270, which represents a potential upside of 37.8% from where the stock is currently trading. Separately, on November 28, Wedbush`s Zarak Khurshid maintained a Buy rating on Illumina shares and has a price target of $200.

In total,2 research analysts have assigned a Hold rating and 3 research analysts have given a Buy rating to the stock. When considering if perhaps the stock is under or overvalued, the average price target is $195.92 which is 3.4% above where the stock opened today.

Illumina, Inc., is developer, manufacturer and marketer of integrated systems for the large scale analysis of genetic variation and biological function.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts